Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,484,320
-$30,770,484 QoQ
Shares Held
137,444
-47.0% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#78
of 1,044 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Derivatives in LH
reported options exposure · as of Mar 31, 2026CallValue
$266,810
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $1,142,807,925 across 20 Diagnostics & Research names. LH ranks #11 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
444,225 | $166,602,144 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
128,987 | $164,782,182 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
277,735 | $139,245,219 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
262,905 | $138,403,708 | |
| 5 | GH |
Guardant Health, Inc.
|
920,807 | $138,148,674 | |
| 6 | NTRA |
Natera, Inc.
|
252,920 | $68,655,134 | |
| 7 | ICLR |
Icon PLC
|
365,945 | $63,568,305 | |
| 8 | QGEN |
Qiagen N.V.
|
1,588,845 | $62,123,839 |
All Filings in LH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,484,320 | 137,444 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $69,254,804 | 259,566 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $266,810 | 1,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $250,880 | 1,000 | Call | Defined | 2026-02-17 | |
| 2025-03-31 | $25,554,619 | 109,799 | Shares | Defined | 2025-07-21 | |
| No filing history on record for this holder in this stock. | ||||||